Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
Clinical trial NCT07059494 · RECRUITING
Trial details
- NCT number
- NCT07059494
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-26
- Primary completion
- 2027-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.